Vitamin E in heart transplantation: Effects on cardiac gene expression

Transplantation

Volumn 81, Issue 5, 2006, Pages 736-745

  Schulte, Ingo ^a   Bektas, Huseyin ^b   Klempnauer, Jürgen ^b   Borlak, Jürgen ^a,b  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Gene expression; Heart transplantation; Vitamin E

Indexed keywords

ACTIN; ALPHA TOCOPHEROL; ATRIAL NATRIURETIC FACTOR; CD31 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; MYOCYTE ENHANCER FACTOR 2; STRUCTURAL PROTEIN; TRANSCRIPTION FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DISEASE MARKER; DONOR SELECTION; DRUG EFFICACY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART MUSCLE REPERFUSION; HEART TRANSPLANTATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C FOS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; VITAMIN BLOOD LEVEL;

ANIMALS; APOPTOSIS; GENE EXPRESSION; HEART TRANSPLANTATION; IMMUNITY; MALE; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; RATS, INBRED LEW; TRANSCRIPTION FACTORS; VITAMIN E;

EID: 33645085062     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000191661.90834.b5     Document Type: Article

References (53)

1. Brigelius-Flohe R, Kelly FJ, Salonen JT, et al. The European perspective on Vitamin E: current knowledge and future research. Am J Clin Nutr 2002; 76: 703.
2. Wang X, Quinn PJ. Vitamin E and its function in membranes. Prog Lipid Res 1999; 38: 309.
3. Fang YZ, Yang S, Wu G. Free radicals, antioxidants and nutrition. Nutrition 2002; 18: 872.
4. Meydani M. Effect of functional food ingredients: vitamin E modulation of cardiovascular diseases and immune status in the elderly. Am J Clin Nutr 2000; 71: 1665.
5. Zhelev Z, Bakalova R. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 2002; 359: 1108.
6. Hodis HN, Mack WJ, LaBree L, et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 1995; 273: 1849.
7. Blatt DH, Leonard SW, Traber MG. Vitamin E kinetics and the function of tocopherol regulatory proteins. Nutrition 2001; 17: 799.
8. Li D, Devaraj S, Fuller C, et al. Effect of alpha-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies. J Lipid Res 1996; 37: 1978.
9. Freedman JE, Keaney JF Jr. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. J Nutr 2001; 131: 374.
10. Ricciarelli R, Zingg JM, Azzi A. The 80th anniversary of vitamin E: beyond its antioxidant properties. Biol Chem 2002; 383: 457.
11. Kaul N, Devaraj S, Jialal I. α-Tocopherol and atherosclerosis. Exp Biol Med 2001; 226: 5.
12. Frenoux JM, Noirot B, Prost ED, et al. Very high alpha-tocopherol diet diminishes oxidative stress and hypercoagulation in hypertensive rats but not in normotensive rats. Med Sci Monit 2002; 8: 401.
13. 11a. Analysis of vitamin E homologs in plasma and tissue: high-performance liquid chromatography. Methods Enzymol 1994; 234: 294.
14. Nakao C, Ookawara T, Kizaki T, et al. Effects of swimming training on three superoxide dismutase isoenzymes in mouse tissues. J Appl Physiol 2000; 88: 649.
15. Chen H, Li D, Saldeen T, et al. Mixed tocopherol preparation is superior to alpha-tocopherol alone against hypoxia-reoxygenation injury. Biochem Biophys Res Commun 2002; 291: 349.
16. Yan T, Li S, Jiang X, Oberley LW. Altered levels of primary antioxidant enzymes in progeria skin fibroblasts. Biochem Biophys Res Commun 1999; 257: 163.
17. Kolodziejczyk SM, Wang L, Balazsi K, et al. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr Biol 1999; 9: 1203.
18. Theriault A, Chao JT, Gapor A. Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes. Atherosclerosis 2002; 160: 21.
19. Yoshida N, Manabe H, Terasawa Y, et al. Inhibitory effects of vitamin E on endothelial-dependent adhesive interactions with leukocytes induced by oxidized low density lipoprotein. Biofactors 2000; 13: 279.
20. Ferber P, Moll K, Koschinsky T, et al. High dose supplementation of RRR-alpha-tocopherol decreases cellular hemostasis but accelerates plasmatic coagulation in type 2 diabetes mellitus. Horm Metab Res 1999; 31: 665.
21. Li D, Saldeen T, Romeo F, Mehta JL. Different isoforms of tocopherols enhance nitric oxide synthase phosphorylation and inhibit human platelet aggregation and lipid peroxidation: implications in therapy with vitamin E. J Cardiovasc Pharmacol Ther 2001; 6: 155.
22. Liu M, Wallmon A, Olsson-Mortlock C, et al. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr 2003; 77: 700.
23. Chang SJ, Lin JS, Chen HH. Alpha-tocopherol downregulates the expression of GPIIb promoter in HEL cells. Free Radic Biol Med 2000; 28: 202.
24. Nelson DP, Wechsler SB, Miura T, et al. Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion. Ann Thorac Surg 2002; 73: 156.
25. Grohe C, Kahlert S, Lobbert K, et al. Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. J Hypertens 1998; 16: 377.
26. Kai H, Muraishi A, Sugiu Y, et al. Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy. Circ Res 1998; 83: 594.
27. Kroumpouzou E, Gomatos IP, Kataki A, et al. Common pathways for primary hypertrophic and dilated cardiomyopathy. Hybrid Hybridomics 2003; 22: 41.
28. Wu S, Chen W, Murphy E, et al. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem 1997; 272: 12551.
29. Thum T, Borlak J. Mechanistic role of Cytochrome P450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury: Therapy through LOX-1 receptor antagonism? Circ Res 2004; 94: 1.
30. Baumer AT, Schumann C, Cremers B, et al. Gene expression of adrenomedullin in failing myocardium: comparison to atrial natriuretic peptide. J Appl Physiol 2002; 92: 1058.
31. Jankala H, Eklund KK, Kokkonen JO, et al. Ethanol infusion increases ANP and p21 gene expression in isolated perfused rat heart. Biochem Biophys Res Commun 2001; 281: 328.
32. Kanda T, Yokoyama T, Imai S, et al. Effect of combination therapy with OK432 and recombinant human interferon-alpha A/D on atrial natriuretic peptide gene expression in mice with viral myocarditis. J Pharmacol Exp Ther 1995; 274: 494.
33. Iso T, Arai M, Wada A, et al. Humoral factor(s) produced by pressure overload enhance cardiac hypertrophy and natriuretic peptide expression. Am J Physiol 1997; 273: 113.
34. Dalton GR, Jones JV, Levi AJ, Levy A. Changes in contractile protein gene expression with ageing and with captopril-induced regression of hypertrophy in the spontaneously hypertensive rats. J Hypertens 2000; 18: 1297.
35. Rapola JM, Virtamo J, Haukka JK, et al. Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial. JAMA 1996; 275: 693.
36. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781.
37. The Hope Study Investigators. Vitamin E supplementation and cardiovascular events in high risk patients. N Engl J Med 2000; 342: 154.
38. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo ITAliano per lo Studio della Sopravvivenza nellInfarto miocardio. Lancet 1999; 354: 447.
39. Li RK, Cowan DB, Mickle DA, et al. Effect of vitamin E on human glutathione peroxidase (GSH-PX1) expression in cardiomyocytes. Free Radic Biol Med 1996; 21: 419.
40. Aratri E, Spycker SE, Breyer I, Azzi A. Modulation of alpha-tropomyosin expression by alpha-tocopherol in rat vascular smooth muscle cells. FEBS Lett 1999; 447: 91.
41. Ricciarelli R, Maroni P, Ozer N, Zingg J, Azzi A. Age-dependent increase of collagenase expression can be reduced by alpha-tocopherol via protein kinase C inhibition. Free Radic Biol Med 1999; 27: 729.
42. Ricciarelli R, Zingg JM, Azzi A. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 2000; 102: 82.
43. Yoshikawa T, Yoshida N, Manabe H, et al. alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells. Biofactors 1998; 7: 15.
44. Clement M, Bourre JM. Graded dietary levels of RRR-gamma-tocopherol induce a marked increase in the concentrations of alpha- and gamma-tocopherol in nervous tissues, heart, liver and muscle off vitamin-E-deficient rats. Biochim Biophys Acta 1997; 15: 17.
45. Beck MA. Nutritionally induced oxidative stress: effect on viral disease. Am J Clin Nutr 2000; 71: 1676.
46. Bell JG, McEvoy J, Tocher DR, Sargent JR. Depletion of alpha-tocopherol and astaxanthin in Atlantic salmon (Salmo salar) affects autooxidative defense and fatty acid metabolism. J Nutr 2000; 130: 1800.
47. Munteanu A, Zingg JM, Azzi A. Anti-atherosclerotic effects of vitamin E - myth or reality? J Cell Mol Med 2004; 8: 59.
48. Reference deleted.
49. Jaxa-Chamiec T, Bednarz B, Drozdowska D, et al. MIVIT Trial Group. Antioxidant effects of combined vitamins C and E in acute myocardial infarction. The randomized, double-blind, placebo controlled, multicenter pilot Myocardial Infarction and VITamins (MIVIT) trial. Kardiol Pol 2005;62:344.
50. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomised controlled trial. JAMA 2005; 294: 56.
51. Szabo G, Soos P, Heger U, et al. Poly(ADP-ribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation. Eur J Cardiothorac Surg 2005; 27: 226.
52. Rabkin DG, Weinberg AD, Spotnitz HM. Optimizing probucol administration to preserve left ventricular compliance after reperfusion injury in the heterotopic rat heart isograft. J Heart Lung Transplant 2003; 22: 959.
53. Murata S, Miniati DN, Kown MH, et al. Superoxide dismutase mimetic m40401 reduces ischemia-reperfusion injury and graft coronary artery disease in rodent cardiac allografts. Transplantation 2004; 78: 1166.